Aitia
Cambridge, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Aitia is a biotechnology company that leverages Causal AI, multi-omics data, and high-performance computing to build Gemini Digital Twins—in silico models of human disease biology. The company's platform aims to uncover novel disease mechanisms and accelerate drug discovery and development for its biopharma partners. Founded in 2019 and based in Cambridge, Massachusetts, Aitia operates at the intersection of AI and life sciences.
AI / Machine LearningDrug Discovery